Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature. 2000, 408: 740-745. 10.1038/35047123.
Article
CAS
PubMed
Google Scholar
Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.
Article
CAS
PubMed
Google Scholar
Marshak-Rothstein A: Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006, 6: 823-835. 10.1038/nri1957.
Article
CAS
PubMed
Google Scholar
Christensen SR, Shlomchik MJ: Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol. 2007, 19: 11-23. 10.1016/j.smim.2006.12.005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002, 3: 196-200. 10.1038/ni758.
Article
CAS
PubMed
Google Scholar
Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K, Ozaki Y, Tomizawa H, Akira S, Fukuhara S: Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subset. J Exp Med. 2002, 195: 1507-1512. 10.1084/jem.20020207.
Article
PubMed Central
CAS
PubMed
Google Scholar
Thibault DL, Graham KL, Lee LY, Balboni I, Hertzog PJ, Utz PJ: Type 1 interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res Ther. 2009, 11: R112-10.1186/ar2771.
Article
PubMed Central
PubMed
Google Scholar
Arthur M, Krieg Jörg Vollmer: Toll-like receptor 7, 8 and 9: linking innate immunity to autoimmunity. Immunological Reviews. 2007, 220: 251-269. 10.1111/j.1600-065X.2007.00572.x.
Article
Google Scholar
Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005, 202: 1131-1139. 10.1084/jem.20050914.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ: Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol. 2007, 18: 1721-1731. 10.1681/ASN.2006101162.
Article
CAS
PubMed
Google Scholar
Akira S, Takeda K: Toll-like receptor signaling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.
Article
CAS
PubMed
Google Scholar
Sun D, Ding A: MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. Nat Immunol. 2006, 7: 375-381. 10.1038/ni1308.
Article
CAS
PubMed
Google Scholar
Bywaters EGL: Still's disease in the adults. Ann Rheum Dis. 1971, 30: 121-133. 10.1136/ard.30.2.121.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M: Adult Still's disease: Review of 228 cases from the literature. J Rheumatol. 1987, 14: 1139-1146.
CAS
PubMed
Google Scholar
Wouters JMGW, van der Veen J, van de Putte LBA, de Rooij DJRAM: Adult Still's disease and viral infection. Ann Rheum Dis. 1988, 47: 764-767. 10.1136/ard.47.9.764.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chen DY, Chen YM, Lan JL, Tzang BS, Lin CC, Hsu TC: Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients. Clin Chim Acta. 2012, 413: 855-860. 10.1016/j.cca.2012.01.027.
Article
CAS
PubMed
Google Scholar
Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M, Suwa A, Hirakata M, Mimori T: Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease: association with chronic articular disease. Rheumatology. 2001, 40: 1398-1404. 10.1093/rheumatology/40.12.1398.
Article
CAS
PubMed
Google Scholar
Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, Nahm DH, Park HS: Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol. 2003, 30: 2422-2427.
CAS
PubMed
Google Scholar
Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL: Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease. Arthritis Rheum. 2007, 57: 1530-1538. 10.1002/art.23088.
Article
PubMed
Google Scholar
Savarese E, Chae OW, Trowitzsch S, Weber G, Kastner B, Akira S, Wagner H, Schmid RM, Bauer S, Krug A: U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood. 2006, 107: 3229-3234. 10.1182/blood-2005-07-2650.
Article
CAS
PubMed
Google Scholar
Yu CF, Peng WM, Oldenburg J, Hoch J, Bieber T, Limmer A, Hartmann G, Barchet W, Eis-Hübinger AM, Novak N: Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation. J Immunol. 2010, 184: 1159-1167. 10.4049/jimmunol.0901706.
Article
CAS
PubMed
Google Scholar
Lombardi V, Van Overtvelt L, Horiot S, Moingeon P: Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. J Immunol. 2009, 182: 3372-3379. 10.4049/jimmunol.0801969.
Article
CAS
PubMed
Google Scholar
Chen DY, Chen YM, Lan JL, Lin CC, Chen HH, Hsieh CW: Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease. Rheumatology (Oxford). 2010, 49: 2305-2312. 10.1093/rheumatology/keq284.
Article
CAS
Google Scholar
Wong CK, Wong PTY, Tam LS, Li EK, Chen DP, and Lam CWK: Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol. 2009, 159: 11-22.
Article
PubMed
Google Scholar
Komatsuda A, Wakui H, Iwamoto K, Ozawa M, Togashi M, Masai R, Maki N, Hatakeyama T, Sawada K: Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol. 2008, 152: 482-487. 10.1111/j.1365-2249.2008.03646.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T: Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992, 19: 424-430.
CAS
PubMed
Google Scholar
Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N: Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. J Rheumatol. 2010, 37: 2369-2376. 10.3899/jrheum.100247.
Article
CAS
PubMed
Google Scholar
Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40: 1725-
Article
CAS
PubMed
Google Scholar
Bombaridier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35: 630-640. 10.1002/art.1780350606.
Article
Google Scholar
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159.
Article
CAS
PubMed
Google Scholar
Chuang HC, Lan JL, Chen DY, Yang CY, Chen YM, Li JP, Huang CY, Liu PE, Wang X, Tan TH: GLK controls autoimmunity and NF-kB signaling by activating PKCθ in T cells. Nature Immunol. 2011, 12: 1113-1118. 10.1038/ni.2121.
Article
CAS
Google Scholar
Testerman TL, Gerster JF, Imbertson LM, Reiter MJ, Miller RL, Gibson SJ, Wagner TL, Tomai MA: Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol. 1995, 58: 365-372.
CAS
PubMed
Google Scholar
Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, Wu YL, Yu CY, Tang Y, Chen JY, Yang W, Wong M, Kawasaki A, Tsuchiya N, Sumida T, Kawaguchi Y, Howe HS, Mok MY, Bang SY, Liu FL, Chang DM, Takasaki Y, Hashimoto H, Harley JB, Guthridge JM, Grossman JM, Cantor RM, Song YW, Bae SC, Chen S, Hahn BH, Lau YL, Tsao BP: Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci USA. 2010, 107: 15838-15843. 10.1073/pnas.1001337107.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N: TLR7 single nucleotide polymorphisms in the 3' untranslated region and intron independently contribute to systemic lupus erythematosus in Japanese woman: a case-control association study. Arthritis Res Ther. 2011, 13: R41-10.1186/ar3277.
Article
PubMed Central
CAS
PubMed
Google Scholar
Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006, 25: 417-428. 10.1016/j.immuni.2006.07.013.
Article
CAS
PubMed
Google Scholar
Kissner TL, Ruthel G, Cisney ED, Ulrich RG, Fernandez S, Saikh KU: MyD88-dependent proinflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice. Innate Immun. 2010, 17: 451-462.
Article
PubMed
Google Scholar
Akira S, Takoda K, Kaisho I: Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2001, 2: 675-680. 10.1038/90609.
Article
CAS
Google Scholar
Matsushima H, Yamada N, Matsue H, Shimada S: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol. 2004, 173: 531-541.
Article
CAS
PubMed
Google Scholar
Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK: Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus. Arthritis Rheum. 2008, 58: 2481-2487. 10.1002/art.23613.
Article
PubMed Central
CAS
PubMed
Google Scholar
Theofilopoulos AN, Baccala R, Beutler B, Kono DH: Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005, 23: 307-336. 10.1146/annurev.immunol.23.021704.115843.
Article
CAS
PubMed
Google Scholar
Ronnblom L, Alm VG: Systemic lupus erythematosus and type 1 interferon system. Arthritis Res Ther. 2003, 5: 68-75.
Article
PubMed Central
PubMed
Google Scholar
Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA. 2003, 100: 2610-2615. 10.1073/pnas.0337679100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Feng X, Wu H, Grossman JM, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP: Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006, 54: 2951-2962. 10.1002/art.22044.
Article
CAS
PubMed
Google Scholar
Dalléra MC, Cardarelli PM, Preston BT, Witte A, Davis JC: Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis. 2005, 64: 1692-1697. 10.1136/ard.2004.033753.
Article
Google Scholar
Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, Kellner ES, Nacionales D, Barker T, Kelly-Scumpia K, van Rooijen N, Kumar H, Kawai T, Satoh M, Akira S, Reeves WH: TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus. J Exp Med. 2008, 205: 2995-3006. 10.1084/jem.20080462.
Article
PubMed Central
CAS
PubMed
Google Scholar
Guiducci C, Tripodo C, Gonng M, Sangaletti S, Colombo MP, Coffman RL, Barrat FJ: Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J Exp Med. 2010, 207: 2931-2942. 10.1084/jem.20101048.
Article
PubMed Central
CAS
PubMed
Google Scholar
Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S: Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998, 9: 143-150. 10.1016/S1074-7613(00)80596-8.
Article
CAS
PubMed
Google Scholar
Lenert PS: Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res Ther. 2006, 8: 203-10.1186/ar1888.
Article
PubMed Central
PubMed
Google Scholar
Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL: Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol. 2007, 37: 3582-3586. 10.1002/eji.200737815.
Article
CAS
PubMed
Google Scholar
Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B: Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum. 2009, 60: 1785-1796. 10.1002/art.24557.
Article
CAS
PubMed
Google Scholar
Merrill JT, Wallace DJ, Petri M, Kirou KA, Yao Y, White WI, Robbie G, Levin R, Berney SM, Chindalore V, Olsen N, Richman L, Le C, Jallal B, White B: Lupus Interferon Skin Activity (LISA) Study Investigators.Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Ann Rheum Dis. 2011, 70: 1905-1913. 10.1136/ard.2010.144485.
Article
CAS
PubMed
Google Scholar
Hamilton-Williams EE, Lang A, Benke D, Davey GM, Wiesmuller KH, Kurts C: Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J Immunol. 2005, 174: 1159-1163.
Article
CAS
PubMed
Google Scholar